Current Status
Not Enrolled
Price
35-65
Get Started

Cost -- Student: $15 | Member: $35 | Non-member: $65

Interesting clinical trial results published on medicinal herbs in the past 18 months will be reviewed. This will include of course what has come out on the efficacy of herbs for treating CoVid-19, as well as other common (and a few uncommon) conditions. Additionally, ongoing and worsening threats to various medicinal species due to the global climate emergency and economic/political conditions around the world will be highlighted (such as the severe threat to Boswellia spp.), and native western American alternatives to these herbs discussed. Expand your material medica and get in touch with your local roots, literally!

Speaker Bio: Eric Yarnell, ND, RH(AHG) graduated from Bastyr University (Seattle, WA) in 1996, after which he completed a two-year residency/apprenticeship with master herbalist and physician Silena Heron, RN, ND in Sedona, AZ. Dr. Yarnell served as chair of the department of botanical medicine at Southwest College of Naturopathic Medicine (SCNM; Tempe, AZ). He has served as senior and associate editor of the Journal of Naturopathic Medicine. He has been in private practice since 1997 specializing in men’s health, urology, and nephrology. He is chief medical officer at Northwest Naturopathic Urology. Dr. Yarnell achieved the rank of professor in the botanical medicine department at Bastyr University; now he works there as an adjunct and clinical research associate (he is also adjunct faculty at BINM and SCNM). He is a co-founder and chief creative officer of Wild Brilliance Press, Inc., a publisher of natural medicine textbooks for students and practitioners. He is also president of Heron Botanicals, Inc. an herbal pharmacy providing hand-crafted, whole plant extracts exclusively to health care providers.  He is CEO of Red Root Pharmaceuticals which works to develop botanical drugs.

**This presentation is worth 1 Category 1 CE credit for Washington NDs.**

Originally presented September 15th, 2022.